Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients

Figure 2. End point is proportion of participants (or catheters) developing catheter-associated bacteriuria. Three trials examined nitrofurazone catheters, 4 pre-1995 trials examined silver-alloy catheters, and 5 post-1995 trials examined silver-alloy catheters. The risk ratio is indicated by the horizontal position of the solid black squares. The 95% CIs around the risk ratios are indicated by the width of the solid lines.
Figure 2. End point is proportion of participants (or catheters) developing catheter-associated bacteriuria. Three trials examined nitrofurazone catheters, 4 pre-1995 trials examined silver-alloy catheters, and 5 post-1995 trials examined silver-alloy catheters. The risk ratio is indicated by the horizontal position of the solid black squares. The 95% CIs around the risk ratios are indicated by the width of the solid lines. Outcomes (total and stratified) of randomized and quasi-randomized clinical trials of currently marketed antimicrobial urinary catheters.

This Article

  1. Ann Intern Med January 17, 2006 vol. 144 no. 2 116-126
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues